Mark Levick is a pharmaceutical physician, board member, and executive coach with extensive experience in biopharmaceutical development. They serve as a board member at InterAx Biotech and LEO Pharma while providing consulting services through Thaxton Philip Consulting. Mark is also an academic tutor and executive coach at the University of Cambridge, where they teach postgraduate students and coach C-suite leaders. Previously, they held senior leadership roles at major companies including Novartis and served as CEO at Alvotech. Mark completed their medical degree at the University of Newcastle and earned a PhD in Vaccine Development from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices